Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05585125 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

A Preliminary Study for INFORMED

Study acronym: PRE-INFORMED
StatusRecruiting
PhasePhase 4
Started
View on ClinicalTrials.gov ↗
Trial flagged as At Risk
Primary completion moved at least 6 months later Jul 2026 → Feb 2027
Enrollment reduced 10% 20 → 18 participants
See other at-risk trials from Weill Medical College of Cornell University

Record History

See every version on ClinicalTrials.gov ↗

  1. Notable Primary completion pushed from Jul 2026 to Feb 2027v10 Show 4 more changesShow less
    • Trial status changed: Enrolling by Invitation → Recruiting
    • Enrollment reduced: 20 → 18 participants
    • Study completion pushed from Jul 2026 to Nov 2027
    • Site details revised
  2. Minor Trial status: Recruiting to Enrolling by Invitation
    • Site details revised
    • Eligibility criteria shortened, about 1 word
    v9
  3. Notable Primary endpoints revised (2)
    • Eligibility criteria expanded, about 63 words
    • Secondary endpoints revised (7)
    • Study description expanded, about 53 words
    v8
  4. Notable Primary endpoints revised (2)v7 Show 4 more changesShow less
    • Primary and study completion dates: Jun 2026 to Jul 2026
    • Start date changed from estimate of Dec 2023 to Feb 7, 2024
    • Eligibility criteria expanded, about 12 words
    • Secondary endpoints: 14 to 7
  5. Notable Start date: Oct 2023 to Dec 2023
    • Primary and study completion dates: Apr 2026 to Jun 2026
    • Eligibility criteria expanded, about 20 words
    v6
Show 4 earlier versionsHide 4 earlier versions
  1. Notable Start date: Jul 2023 to Oct 2023
    • Primary and study completion dates: Jan 2026 to Apr 2026
    v5
  2. Notable Start date: Apr 2023 to Jul 2023
    • Primary and study completion dates: Oct 2025 to Jan 2026
    v4
  3. Minor Re-verified, no change to tracked fieldsv3
  4. Notable Trial status: Not Yet Recruiting to Recruitingv2 Show 4 more changesShow less
    • Primary completion date: Jan 2024 to Oct 2025
    • Start date: Dec 2022 to Apr 2023
    • Study completion date: Jan 2025 to Oct 2025
    • Site details revised
  1. Minor Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Investigators will determine whether N-of-1 trials, as a pragmatic, participant-centered approach to medication optimization that can overcome key barriers of deprescribing, can lead to increased participant confidence regarding their preference to continue or discontinue beta-blockers in older adults with Heart Failure with Preserved Ejection Fraction (HFpEF).
Trial Details
NCT Number NCT05585125
Lead Sponsor Weill Medical College of Cornell University
Collaborators: National Institute on Aging (NIA)
Conditions
(from sponsor)
Heart Failure, Heart Failure, Diastolic, Heart Failure With Preserved Ejection Fraction, Cardiac Failure, Heart Diseases
Related terms Heart Diseases, Heart Failure, Heart Failure, Diastolic
Enrollment 18 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov